About Us
“Beau-Vous” derives from French, meaning Beautiful You. For more than 30 years, Beauvous Corporation has been dedicated to enhancing the beauty and well-being of our customers. We continue to invest tirelessly in research, innovation, and product development to deliver excellence you can trust.
Founded in 1993, Beauvous Corporation is a pharmaceutical distribution company that develops and supplies non-reimbursable medical products and wellness cosmetics designed to support hospital management and patient care.
learn about us
For more than 30 years, Beauvous Corporation has been committed to enhancing the beauty and well-being of our customers, continuously striving for growth through relentless effort and investment.
Since its establishment in 1993, Beauvous Corporation has collaborated with leading partners to introduce innovative healthcare solutions. Beginning with recombinant human growth hormone Eutropin® from LG Chem (formerly Lucky Goldstar’s pharmaceutical division), we expanded to include Dysport® (Botulinum A type Toxin) from Ipsen Korea and Melsmon® placenta extract. We also supply U.S. imported hospital-grade functional foods such as MDaid® and nutritional supplements from Pure Encapsulations®, supporting healthcare providers and clinics in patient care.
Since 2007, Beauvous Corporation has further diversified its portfolio with products such as the so-called “Garlic Injection” (Furtiamine®), PPC-based Lipobean®, high-dose Vitamin D BON® injection from France, GPC-based Alfocholine®, Ornithine-based Paramel infusion®, and bee venom Apitoxin® injections, among others — continuously developing and distributing products to meet evolving medical and wellness needs.
Beauvous History
Committed to Delivering Trusted Products for a Healthy Life
Beauvous Corporation was founded, initiating the distribution of non-reimbursable wellness pharmaceuticals to hospitals and medical institutions in Korea, laying the foundation for its distribution network. Building on quality and trust, the company established stable partnerships and expanded its market presence.
Through partnerships with global pharmaceutical companies, Beauvous Corporation strengthened its distribution of imported products and enhanced a hospital-centered supply system for customized solutions. During this period, we expanded our portfolio to include a wide range of healthcare and aesthetic pharmaceuticals tailored to customer needs.
Beauvous Corporation has expanded its distribution portfolio with premium pharmaceutical brands such as Alfocholine®, Furtiamine®, and Eutropin (LG Growth Hormone). We continue to play a key role as a trusted partner in supporting sustainable healthcare environments. With over 31 years of accumulated expertise, we remain highly responsive to the evolving needs of medical institutions and are dedicated to consistent, long-term growth.